Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
8,574 total articles
RTX combines commercial aerospace (Pratt & Whitney, Collins) with high-margin defense businesses (Raytheon Intelligence & Space, Raytheon Missiles & Defense). At $186.59 the stock offers durable free cash flow ($8.46B), a modest dividend, and a balance-sheet that finances growth and buybacks. We outline an actionable long trade with entry, stop and…
FitLife Brands (FTLF) shows early signs the Irwin Naturals acquisition is accretive: EPS of $0.64, a reasonable P/E near 18.6, EV/EBITDA ~12.4, and bullish technical momentum. We outline a mid-term long trade with clear entry, stop and target alongside catalysts and risks.
VSE's Aviation business is getting a growth jolt from recent Precision Aviation Group integration and MRO demand. The stock is trading with momentum and constructive technicals, but valuation is rich and headline risk is real. This trade proposes a mid-term swing long with a strict stop and clear targets.
Salesforce has been punished with a deep multiple reset even as revenue growth remains healthy and free cash flow is strong. At roughly $150 a share the stock offers a low-teens P/E, robust FCF generation and tangible AI and M&A catalysts. This trade idea lays out an entry at $150.215, a disciplined stop and a $210 target over a 180-trading-day hor…
Solventum (SOLV) looks like a compelling swing trade after a modest pullback. The stock trades at an attractive P/E (~9-9.3) relative to growth, carries a buyback tailwind and solid ROE, but the balance sheet and negative free cash flow add real risk. Entry around $76, stop at $73.75, target $88 over a mid-term 45 trading day horizon.
<p>Boston Scientific (BSX) has tumbled from a $109.50 52-week high to trade near $44.27 today, punished by guidance cuts and procedure mix headwinds. Fundamentals still show scale, cash generation and manageable leverage, while recent positive trial data and a strategic push into TAVR create asymmetric upside. This is a tactical, mid-term trade loo…
Tecnoglass is trading at a reasonable multiple (P/E ~14, EV/EBITDA ~8.5) with a healthy ROE (20%) and a steady quarterly dividend. I expect tariff relief and easing trade costs to lift gross margins and free up near-term cash flow. This is a long trade idea with a clear entry, stop and target tied to fundamental and technicals.
Murphy Oil is a cash-generative E&P with a moderate balance sheet and a growing set of catalysts — including reported Côte d'Ivoire exploration upside and cost savings from a new FPSO — that justify a long trade into a 180-trading-day horizon. The company trades around book value and cheap on EV/EBITDA, while paying a ~3.8% yield. We lay out an ent…
Celestica is morphing from a diversified EMS provider into a prime assembler of custom AI hardware. Recent quarter beats, a raised $19B revenue guide and outsized free cash flow underpin a long trade. This plan targets $420 with a $320 stop, horizon 180 trading days.
Hertz's recent equity offering sparked a 40% drop on 06/24/2026, but dilution is only the headline. The company's negative free cash flow (about -$9.65B), a tiny market cap (~$876M) versus an $18.56B enterprise value, and persistent operational losses argue the equity is impaired. We downgrade and propose a tactical short: enter at $2.80, stop at $…
NIO's recent delivery acceleration (37,705 units in May, +62.3% YoY) and a stepped-up vehicle gross margin (18.8% in Q1) suggest the stock is forming a technical floor near $4.80. With a $12.15B market cap, an RSI near 33 and heavy short interest, a contained, mid-term long trade offers asymmetric upside to $7.00 with a clear $4.20 stop.
BV Financial (BVFL) is trading near book and at a modest P/E while generating solid free cash flow and carrying low leverage. We outline a mid-term long trade with entry at $21.35, a $25.00 target and a $19.50 stop, driven by valuation upside, improving technical momentum and an attractive cash flow profile.
Nintendo is trading near its 52-week low with a $54.1B market cap, a 3.0% yield, and a mid-teens PE. Near-term macro and memory-cost noise has pushed the stock lower, but franchise monetization (games, movies, parks), Switch 2 sell-through, and easing input costs create a high-conviction entry for a mid-term long trade.
Molson Coors trades well below historical highs on punchy yield and attractive EV multiples despite near-term volume pressure. With enterprise value around $13.5B, free cash flow north of $1.1B and an EV/EBITDA near 6.6x, the stock looks priced for a soft demand environment. This is a tactical swing idea: buy at $40.71, stop at $37.50, target $49.0…
Snap is beaten up and deeply discounted by market sentiment after a controversial $2,195 AR glasses launch and persistent regulatory headlines. Fundamentals show positive free cash flow and a sub-$8 billion market cap that make a small, asymmetric options bet sensible. We lay out four independent catalysts that could re-rate the stock, a concrete t…
Teradata is a cash-generative, mid-cap cloud analytics company trading at a single-digit P/E and attractive EV metrics. With cloud ARR growing and free cash flow of $670M, TDC offers a lower-cost way to play enterprise AI/multi-cloud adoption. This trade idea outlines an entry at $31.75, a $42.00 target and a $27.50 stop — a long-term tactical posi…
Tencent Music (TME) is trading near its 52-week low after a user-headline driven selloff. Recent strategic moves - including a bigger dividend, a pivot toward higher-paying users, and a buyer-side acquisition - make the stock worth a tactical, mid-term long. Valuation (~$13.1B market cap, P/E ~9.9, P/B ~1.09) and a 2.85% yield create an asymmetric …
Toast reported 26% ARR growth and is generating substantial free cash flow, yet the stock trades well below its 52-week highs. I outline a trade plan to buy on strength around $26.81 with a $35 target over the next 45 trading days, a $23 stop, and a clear set of catalysts and risks to watch.
Enova (ENVA) has the balance-sheet durability and free-cash-flow profile to justify a re-rate if the Grasshopper acquisition accelerates cross-sell and platform economics. The business is cash-rich, profitable, and sitting at a 52-week high. This trade targets a measured re-rating toward a mid-teens-to-low-twenties P/E multiple while protecting aga…
Nvidia is trading off recent highs into a technical pullback, but the fundamental backdrop - massive data-center AI spend, 85% revenue growth reported recently, $119B in free cash flow and an industry-leading ROE - argues for a tactical long. Entry at $193, stop at $170, target $260 over a 180 trading-day horizon balances upside with defined risk-m…
Slate Grocery REIT (SRRTF) is an income-first play: a $736M market-cap REIT trading near book with a 7.1% yield and a P/E of ~16.8. For investors seeking stable monthly distributions and limited upside volatility, I view SRRTF as a buy-and-hold with a defined entry, stop and target over a 180-trading-day horizon. The trade rests on steady grocery-a…
Alto Ingredients has moved from distress to profitability, with free cash flow of $30.7M, a modest debt load and recent bolt-on M&A that should lift margins. At a market cap around $384M and a P/E in the mid-teens, the stock offers a swing trade opportunity if management continues execution and commodity dynamics remain supportive.
Ducommun (DCO) is a small-cap aerospace and defense contractor showing accelerating commercial aerospace growth and margin expansion while defense demand—driven by air defense and missile systems—creates a durable revenue runway. The company trades near a 52-week high and at a premium EV/EBITDA multiple (~25x); we view that premium as justified if …
Booking Holdings (BKNG) has pulled back from last year's highs, trading near $181.79 after a low of $150.14 earlier this year. Fundamentals still look solid: roughly $140.6B market cap, free cash flow near $9.03B and a mid-teens P/FCF. Technicals and short-covering dynamics favor a rebound. This is a mid-term tactical long with a strict stop — trad…
GSK’s $10.6B acquisition of Nuvalent and recent regulatory wins shift the company from defensive big pharma toward a credible oncology growth story. With a $105.1B market cap, a 3.5% yield and attractive technical momentum, GSK offers a swing trade to capture re-rating as market focus moves to oncology assets and pipeline optionality.
